Published January 27, 2022 | Version v.1
Journal article Restricted

St. George's mushroom, Calocybe gambosa (Fr.) Donk: A promising source of nutrients and biologically active compounds

  • 1. Department of Pharmacognosy, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, 11322, Belgrade, Republic of Serbia
  • 2. Institute for Oncology and Radiology of Serbia, Pasterova 11, 11000, Belgrade, Republic of Serbia
  • 3. Mega Trade System d.o.o., Dunavska 1c, 78000, Banja Luka, Republic of Srpska
  • 4. Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Dr Subotića 5, 11000, Belgrade, Republic of Serbia
  • 5. Institute of Public Health Kragujevac, Nikole Pašića 1, 34000, Kragujevac, Republic of Serbia

Description

The composition of biologically active compounds of Calocybe gambosa (Lyophyllaceae) was analysed, and the antioxidant and cytotoxic activities were tested in vitroC. gambosa was low in energy, fat, and carbohydrates, but rich in proteins and fibres. The total polyphenol content in the extracts was low (23.08 ± 0.67 in aqueous and 24.99 ± 4.25 μg GA mg−1 of extract in methanolic extract). The methanolic extract showed anti-DPPH radical activity with an IC50 of 626.10 ± 25.20 μg mL−1. The sample of C. gambosa is rich in nucleotides and amino acids responsible for its pleasant taste. The nucleoside and 5′-monophosphates contents were 0.97 mg g−1 and 2.32 mg g−1 of dry mushroom, respectively. The contents of essential and non-essential amino acids were 18.41 ± 0.06 and 41.75 ± 0.30 mg g−1 d.w., respectively. The percentages of saturated and unsaturated fatty acids were 42.6% and 57.4%, respectively. The most abundant water-soluble and fat-soluble vitamins were B1 and E, respectively. Cytotoxic effect of the extracts was examined against different cancer cell lines, and the best cytotoxicity was showed by the peptide extract against colon cancer cell line LS174.

Notes

This research was funded by the Ministry of Education, Science and Technological Develop- ment, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-9/2021-14/200161.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

The full thext could be reached with password only.

You are currently not logged in. Do you have an account? Log in here

Additional details

Related works

Is part of
0139-3006 (ISSN)

Funding

Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 451-03-68/2020-14/200161 (University of Belgrade, Faculty of Pharmacy) 200161
Ministry of Education, Science and Technological Development